EnPlusOne Biosciences

📍 Watertown, United States👥 12 employees💰 Last funded 2022
Biotechnology Research🌐 enplusonebio.com
Website LinkedIn
EnPlusOne is on a mission to bring RNA and RNA solutions to the world. Its ezRNA™ synthesis platform is a stepwise innovation that can incorporate a diverse array of nucleotide modifications and promises a manufacturing process that can sustainably deliver therapeutic RNA at commercial scales. In addition to direct RNA synthesis, EnPlusOnes ezRNA™ platform supports a vast array of RNA solution applications. For more information, please visit www.enplusonebio.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in EnPlusOne Biosciences?
EnPlusOne Biosciences has 1 investors on record on gritt.io.
When did EnPlusOne Biosciences last raise funding?
The most recent investment in EnPlusOne Biosciences recorded on gritt.io was in 2022.
What industry is EnPlusOne Biosciences in?
EnPlusOne Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EnPlusOne Biosciences based?
EnPlusOne Biosciences is headquartered in Watertown, United States.